Skip to main navigation Skip to search Skip to main content

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials

  • Jong Wook Lee
  • , Kohei Hosokawa
  • , Jun Ho Jang
  • , Naoshi Obara
  • , Masashi Sawa
  • , Kensuke Usuki
  • , Gaku Oshikawa
  • , Masahiro Kizaki
  • , Koji Nagafuji
  • , Ting An Lin
  • , Hitoshi Hanamoto
  • , Yeung Chul Mun
  • , Toshiro Kawakita
  • , Kazunori Imada
  • , June Won Cheong
  • , Sung Soo Park
  • , Takayuki Tabayashi
  • , Masaru Gamou
  • , Kenta Murotani
  • , Hirohito Yamazaki

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish
Pages (from-to)1955-1959
Number of pages5
JournalBritish Journal of Haematology
Volume209
Issue number4
DOIs
StatePublished - Oct 2026

Keywords

  • aplastic anaemia
  • haematological response rate
  • late responder
  • long-term
  • observational study
  • romiplostim
  • sustained response

Cite this